Cardiovascular Gastro/Intestinal Gynecology Neuro Orthopedics Ophthalmology Pulmonary Urology Vascular

Ekos was formed to commercialize products based on the innovative research of Drs. Shunro and Katsuro Tachibana of Fukuoka University School of Medicine in Japan. Ekos applies low energy, localized ultrasound to facilitate, enhance, control or activate drugs at a targeted tissue site. The company's focus is to enhance thrombolysis in stroke. Seacoast Technologies, Inc. has developed hypothermia-based therapies to protect patients who suffer from various neurological emergencies, including head trauma and stroke. Therus Corporation is a seed stage company formed to exploit clinical applications of High Intensity Focused Ultrasound. The management team is evaluating the best commercial applications, including acoustic hemostasis, arterial sealing and tumor ablation, with the long-term vision of non-invasive, image-guided surgery.